Welsh, Carson, Anderson & Stowe

The firm’s 15th flagship vehicle targets mid-market buyout opportunities primarily in North America, according to documents prepared for a recent LP meeting.

The stock is listed under the ticker symbol “LMRI.”

'Historically, everything required an operation,' said Lee Equity's Mark Gormley. 'Now, the new drugs and treatments are a lot more specific and sensitive.'

Herndon, Virginia-based SoldierPoint provides digital health solutions that empower organizations to expand access to care, improve outcomes and modernize healthcare delivery for veterans.

Most recently, he served as president of Aetna.

ACD’s existing backers The American Institute of Architects and True Wind will continue as investors, board members and key strategic partners.

Great Point Partners, Hildred Capital and Welsh, Carson, Anderson & Stowe are among the PE firms investing in orthopedic care providers.

CSA currently manages 16 facilities in five states that perform over 100,000 orthopedic, total joint replacement, spine, ophthalmology, ENT, urology and GI procedures annually.

Lone View’s founders are Rishi Chandna and Doug Ceto, veterans of Golden Gate Capital’s technology practice, and Jim Schaper, ex-chairman and CEO of Ivanti.

Chen joined Runway in 2017, Lai came on board in 2020 and Khubani joined in 2018.

As interest rates rise, with the potential for debt to become more expensive, operational talent and the ability to achieve revenue goals through improvements in operations becomes much more in focus.

Sherrese Clarke Soares, founder of HarbourView Equity Partners, sets the tempo for women aspiring to the C-suite. We salute 10 accomplished professionals and their achievements in a hyper-competitive field of play.

This theme is being embraced by investors across the spectrum and could be a boon for payors, providers and, most importantly, patients.

Founded as one center in Minneapolis 40 years ago, the company formerly known as Center for Diagnostic Imaging envisions doubling in size over the next two years as it looks to transform the industry with a multi-pronged strategy, CEO Kim Tzoumakas says.

The Credit Suisse-run process, targeting strategic buyers, comes six-plus years after the Canadian pension fund's LBO of the anesthesia platform.

G-CON, a specialist in portable cleanrooms that support biotech manufacturing, is likely to trade hands at a more than $400m valuation.